Found 51 matching trials
Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease PHASE3 The study is a prospective, non-controlled, open-label multi-centre pilot s...
Show More Learn More & Join Trial
Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer PHASE3 Cancer related anemia (CRA) is a common sign occurring in more than 30% of ...
Show More Location
Allan Blair Cancer Centre
Learn More & Join Trial
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life PHASE4 This study will address whether the additional use of Ferric Derisomaltose ...
Show More Location
China-Japan Friendship Hospital
Learn More & Join Trial
Iron Replacement in Oesophagogastric Neoplasia PHASE4 40 eligible patients with confirmed esophageal or gastric adenocarcinoma an...
Show More Location
Nottingham Univeristy Hospitals NHS Trust
Learn More & Join Trial
IV Iron-induced Hypophosphatemia After RYGB PHASE4 The primary objective of the study is to compare the incidence of hypophosp...
Show More Learn More & Join Trial
Intravenous Iron for Correction of Anaemia After Colorectal Surgery PHASE4 This 4-week prospective double blind anaemia management study evaluates the...
Show More Location
Department of Anaesthesiology, Lithuanian University of Health Sciences
Learn More & Join Trial
IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose PHASE3 The purpose of the trial is to evaluate and compare the effect of iron isom...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF) PHASE4 This study will address whether the additional use of Ferric Derisomaltose ...
Show More Location
China-Japan Friendship Hospital
Learn More & Join Trial
Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD PHASE1 The purpose of this study is to assess the pharmakokinetic properties of hi...
Show More Location
Multiple Locations
Learn More & Join Trial
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN PHASE4 This study will address whether the additional use of Intravenous (IV) iron...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial